furosemide has been researched along with adrenomedullin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eto, T; Kawamoto, M; Kita, T; Kitamura, K; Kuwasako, K | 1 |
| Benešová, K; Goldbergová-Pávková, M; Jarkovský, J; Krejčí, J; Lábr, K; Ludka, O; Málek, F; Ošťádal, P; Pařenica, J; Špinar, J; Špinarová, L; Špinarová, M | 1 |
2 other study(ies) available for furosemide and adrenomedullin
| Article | Year |
|---|---|
Short-term modulation of the renin-angiotensin system does not alter plasma adrenomedullin concentration in humans.
Topics: Adrenocorticotropic Hormone; Adrenomedullin; Adult; Antihypertensive Agents; Captopril; Female; Furosemide; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renovascular; Male; Middle Aged; Peptide Fragments; Peptides; Proteins; Renin; Renin-Angiotensin System | 1998 |
Relation between Mid-Regional Pro-Adrenomedullin in Patients with Chronic Heart Failure and the Dose of Diuretics in 2-Year Follow-Up-Data from FAR NHL Registry.
Topics: Adrenomedullin; Aged; Biomarkers; Diuretics; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Peptide Fragments; Prognosis; Protein Precursors; Registries; Risk Assessment; Sodium Potassium Chloride Symporter Inhibitors | 2022 |